分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Irbesartan ameliorates high‑glucose‑induced epithelial‑mesenchymal transition by downregulating the expression of NLRP3 in HK‑2 cells

Qing Deng, Xiujuan Liu, Dan Wen, Yuhua Cheng, Qing Zhao, Yu Wang, Yu Xiang, Qinkai Chen, Jinlei Lv

Journal:Molecular Medicine Reports

IF:5

DOI:10.3892/mmr.2026.13940

PMID:

Published:2026-06-17

research field:神经科学分子生物学药理学传染病学结构生物学遗传学分子心脏病学分子外科学病理学生物化学

Abstract

Diabetic kidney disease is a frequent complication of diabetes and the predominant cause of end‑stage renal disease. However, the pathogenesis of diabetic kidney disease has not been fully elucidated. HK‑2 cells cultured in vitro were randomly divided into control, high glucose, high glucose + MCC950 and high glucose + irbesartan groups. The present study detected the mRNA and protein expression of NLRP3, caspase‑1, NF‑κB p65, α‑SMA, vimentin and N‑cadherin using reverse transcription‑quantitative PCR and western blotting. The present study also detected the protein expression of vimentin using immunocyte fluorescence. High glucose (40 mM) significantly increased the mRNA and protein levels of NLRP3, NF‑κB p65, caspase‑1 and epithelial‑mesenchymal transition (EMT) markers; these effects were attenuated by MCC950 and irbesartan administration. These results indicated that high glucose stimulation upregulated the expression of NLRP3 in HK‑2 cells and promoted the expression of EMT‑associated factors. Irbesartan inhibited the activation of the NLRP3 inflammasome and downregulated the expression of EMT‑related factors, which provided a basis for potential new strategies for the treatment of diabetic nephropathy.

本文使用的Yeasen产品

购物车
客服
转染试用